Crispr Therapeutics Ag (CRSP)

04:44 AM

CRISPR Therapeutics (NASDAQ:CRSP) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat

04:44 AM

04:06 AM

Is CRISPR Therapeutics AG a good long term investmentUnmatched profit potential - Autocar Professional

04:06 AM

09:09 AM

CRISPR Stock (CRSP) Continues to Sizzle on Insider Deal - TipRanks

09:09 AM

12:07 PM

3 Monster Stocks in the Making to Buy Right Now - The Motley Fool

12:07 PM

Jul 20, 2025

CRISPR Therapeutics (CRSP) Soars 18% After $51-Million Insider Trading - MSN

Jul 20, 2025

Jul 20, 2025

What analysts say about CRISPR Therapeutics AG stockRecord-setting profit potential - PrintWeekIndia

Jul 20, 2025

Jul 20, 2025

What drives CRISPR Therapeutics AG stock priceFree Stock Chart Pattern Guide - Autocar Professional

Jul 20, 2025

Jul 19, 2025

Q2 EPS Estimate for CRISPR Therapeutics Lifted by Analyst - MarketBeat

Jul 19, 2025

Jul 19, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $71.75 Average Price Target from Analysts - MarketBeat

Jul 19, 2025

Jul 19, 2025

Crispr Therapeutics AG Stock Soars Amid Insider Confidence - TipRanks

Jul 19, 2025

Jul 18, 2025

Is It Worth Investing in CRISPR Therapeutics (CRSP) Based on Wall Street's Bullish Views? - MSN

Jul 18, 2025

Jul 18, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) Director Acquires $51,499,918.36 in Stock - MarketBeat

Jul 18, 2025

Jul 18, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.7%What's Next? - MarketBeat

Jul 18, 2025

Jul 18, 2025

CRSP’s Astounding Gains: Should Investors Jump In? - timothysykes.com

Jul 18, 2025

Jul 18, 2025

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares - TipRanks

Jul 18, 2025

Jul 18, 2025

Crispr stock soars after director buys $51.5 million in shares - Investing.com

Jul 18, 2025

Jul 18, 2025

CRISPR Therapeutics Breaks Ground with Promising Phase 1 Trial Advances - timothysykes.com

Jul 18, 2025

Jul 18, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Hits New 52-Week High Following Insider Buying Activity - MarketBeat

Jul 18, 2025

Jul 18, 2025

Crispr director George buys $51.5M of shares (CRSP:NASDAQ) - Seeking Alpha

Jul 18, 2025

Jul 18, 2025

Crispr Therapeutics stock hits 52-week high at 62.32 USD - Investing.com

Jul 18, 2025

Jul 17, 2025

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG! - TipRanks

Jul 17, 2025

Jul 16, 2025

CRISPR Therapeutics (CRSP) Moves 9.6% Higher: Will This Strength Last? - MSN

Jul 16, 2025

Jul 16, 2025

Leavell Investment Management Inc. Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 16, 2025

Jul 15, 2025

CRISPR Therapeutics AG (CRSP) Declines More Than Market: Some Information for Investors - MSN

Jul 15, 2025

Jul 15, 2025

B & T Capital Management DBA Alpha Capital Management Buys New Position in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Jul 15, 2025

Jul 14, 2025

(CRSP) Trading Report - news.stocktradersdaily.com

Jul 14, 2025

Jul 14, 2025

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade) - Seeking Alpha

Jul 14, 2025

Jul 12, 2025

Crispr Therapeutics AG Stock Surges on Strategic Moves and Promising Clinical Updates - AInvest

Jul 12, 2025

Jul 12, 2025

Crispr Therapeutics AG Stock Soars Amid Strategic Moves - TipRanks

Jul 12, 2025

Jul 12, 2025

CRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech Rally - MSN

Jul 12, 2025